We need to understand the long-term impact of treatments used for children who survive medulloblastoma. Forming a unique team of internationally-leading experts and future leaders will help to create a network prepared for the development and delivery of future clinical advances so we can better help children who suffer life-long side-effects of their disease and therapy.
SMILE: An International network for Medulloblastoma Survivorship and Late-Effects
Professor Steve Clifford
Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer
Newcastle upon Tyne, NE1 7RU
1 July 2022